Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 2.77 is 16% below its 5-year average of 3.28, near the low end of its 5-year range (0.00–20.00).
As of the fiscal period ended Tuesday, June 30, 2026. 6.82% above its 12-month average of 2.59.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.77.
CURRENT RATIO
2.77
CURRENT RATIO AVG TTM
2.59
CURRENT RATIO AVG 3Y
2.32
CURRENT RATIO AVG 5Y
3.28
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+6.82%
CURRENT VS 3Y AVG
+19.57%
CURRENT VS 5Y AVG
-15.65%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-26.15%
vs the sector median at left
Elicio Therapeutics, Inc.
Market Cap
$36.31M
Current Ratio
2.77
TTM Avg
2.59
3Y Avg
2.32
5Y Avg
3.28
Market Cap
$36.85M
Current Ratio
3.10
TTM Avg
1.66
3Y Avg
0.84
5Y Avg
1.97
Market Cap
$35.71M
Current Ratio
0.18
TTM Avg
0.18
3Y Avg
0.32
5Y Avg
0.43
Market Cap
$35.19M
Current Ratio
7.07
TTM Avg
2.75
3Y Avg
16.37
5Y Avg
28.22
Market Cap
$37.73M
Current Ratio
48.81
TTM Avg
25.84
3Y Avg
15.89
5Y Avg
15.79
Market Cap
$34.42M
Current Ratio
11.47
TTM Avg
9.93
3Y Avg
10.68
5Y Avg
16.03
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Elicio Therapeutics, Inc. (ELTX) | $36.31M | 2.77 | 2.59 | 2.32 | 3.28 |
| QT Imaging Holdings, Inc. (QTI)vs › | $36.85M | 3.10 | 1.66 | 0.84 | 1.97 |
| EUDA Health Holdings Limited (EUDA)vs › | $35.71M | 0.18 | 0.18 | 0.32 | 0.43 |
| Edesa Biotech, Inc. (EDSA)vs › | $36.61M | 2.76 | 5.79 | 4.84 | 5.49 |
| DocGo Inc. (DCGO)vs › | $35.56M | 1.66 | 2.38 | 2.37 | 2.73 |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.19M | 7.07 | 2.75 | 16.37 | 28.22 |
| Incannex Healthcare Limited (IXHL)vs › | $37.73M | 48.81 | 25.84 | 15.89 | 15.79 |
| Elutia Inc (ELUT)vs › | $34.48M | 1.77 | 1.46 | 1.21 | 1.48 |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.42M | 11.47 | 9.93 | 10.68 | 16.03 |
| Nephros, Inc. (NEPH)vs › | $38.11M | 4.07 | 4.68 | 4.80 | 6.06 |
Current Ratio
2.77
Quick Ratio
2.77
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 2.77 |
| 2026-03-31 | 2.24 |
| 2025-12-31 | 2.38 |
| 2025-09-30 | 3.29 |
| 2025-06-30 | 2.28 |
| 2025-03-31 | 1.83 |
| 2024-12-31 | 1.80 |
| 2024-09-30 | 3.40 |
| 2024-06-30 | 0.88 |
| 2024-03-31 | 2.37 |
| 2023-12-31 | 1.68 |
| 2023-09-30 | 1.74 |
| 2023-06-30 | 3.45 |
| 2023-03-31 | 20.00 |
| 2022-12-31 | 1.56 |
| 2022-09-30 | 6.93 |
| 2022-06-30 | 0.00 |
| 2022-03-31 | 7.34 |
| 2021-12-31 | 8.08 |
| 2021-09-30 | 5.82 |
| 2021-06-30 | 5.83 |
| 2021-03-31 | 4.29 |
| 2020-12-31 | 0.38 |
| 2020-09-30 | 0.19 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 0.23 |
